Pharmafile Logo
Pharmafocus logo
Advanced Search
Neil Woodford

Investment group renews calls for GSK to split

January 8, 2016
Medical Communications, Sales and Marketing GSK, Neil Woodford, investment, restructure

Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …

News
Valeant logo

Why 2016 could be a make or break year for Valeant

January 8, 2016
Medical Communications, Sales and Marketing Howard Schiller, J. Michael Pearson, Michael Pearson, Valeant

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …

Feature
FDA sign

FDA review for Sanofi and Regeneron’s biologic arthritis drug

January 8, 2016
Medical Communications, Sales and Marketing FDA, Regeneron, Sanofi, biologics, rheumatoid arthritis, sarilumab

The FDA has accepted for review a Biologics License Application (BLA) from Sanofi and Regeneron for the rheumatoid arthritis treatment …

News
Roche building

Roche presents new data for advanced bladder cancer immunotherapy

January 8, 2016
Medical Communications, Research and Development Roche, atezolizumab, bladder cancer

Roche has announced updated results from a pivotal Phase II study, showing its investigational cancer immunotherapy atezolizumab extended median progression …

News
Novartis image

Novartis and Qualcomm to develop smart inhaler technology for COPD

January 8, 2016
Manufacturing and Production, Medical Communications COPD, Novartis, Qualcomm Life, breezhaler, digital inhaler, qualcomm

Novartis has enlisted Qualcomm life to help the pharma giant develop the ‘next generation’ of its Breezhaler device for patients …

News
victoria_photo_feb_14

New head for AI drug discovery firm Molplex

January 7, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Molplex, Victoria Camargo

The artificial intelligence drug discovery company Molplex has appointed Victoria Camargo as its new chief executive. Camargo replaces the co-founder …

Appointment
HIV infected cell

ViiV and Janssen to test new HIV regimen in Phase III trial

January 7, 2016
Manufacturing and Production, Medical Communications, Research and Development Edurant, HIV, Janssen, ViiV Healthcare, cabotegravir, collaboration, phase III, rilpivirine

Janssen has formalised its collaboration with ViiV Healthcare on the Phase III development and commercialisation of a two-drug regimen to …

News
dr_paolo_paoletti

PsiOxus Therapeutics appoints Dr Paolo Paoletti as chairman of the board

January 7, 2016
Manufacturing and Production, Medical Communications, Research and Development Cancer, Dr Paolo Paoletti, GSK, PsiOxus Therapeutics, immuno-oncology, oncology

Immuno-oncology company PsiOxus Therapeutics has appointed Kesios Therapeutics chief executive, and former president of GSK Oncology, Dr Paolo Paoletti, as chairman …

Appointment
Merck image

Merck and Biocartis partner on new biomarker test for colorectal cancer

January 7, 2016
Research and Development BRAF mutations, Diagnostics, Erbitux, Merck, RAS metations, diagnostic tests, metastic colorectal cancer

Merck has signed a collaboration agreement with diagnostics company Biocartis for the development and commercialisation of a new test for …

News
Janssen image

Janssen, Enterome and Kymab in research collaborations

January 7, 2016
Research and Development Crohn's, Crohn’s disease, Enterome, Janssen, MD Anderson, alliance, antibodies, collaboration, crohn's disease, immuno-oncology, kymab, research

Several pharma companies have announced new collaborations, to research potential new drugs for Crohn’s disease, and immuno-oncology treatments for cancer. …

News
ian_green

Terrence Higgins Trust announces new CEO

January 6, 2016
Medical Communications AIDS, HIV, Terrance Higgins Trust

Leading UK-based HIV and sexual health charity The Terrence Higgins Trust has announced the appointment of Ian Green as the …

Appointment
Gilead logo

Gilead terminates Phase II simtuzumab IPF study

January 6, 2016
Research and Development Gilead, IPF, idiopathic pulmonary fibrosis, simtuzumab

Gilead Sciences has announced the termination of its Phase II clinical study of the investigational monoclonal antibody simtuzumab in patients …

News
Exercise prostate cancer

Trial launched to test exercise as prostate cancer treatment

January 6, 2016
Research and Development Cancer Research UK, active surveillance, exercise, prostate cancer

Cancer Research UK has launched a study to determine if exercise could help men with prostate cancer, the UK’s most …

News
Dr Reddy's generic nexium

Dr Reddy’s relaunches generic Nexium in blue after AstraZeneca lawsuit

January 6, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, acid reflux, esomeprazole, lawsuit, purple pill

Dr Reddy’s has relaunched its generic version of AstraZeneca’s blockbuster heartburn drug Nexium  in the US, changing the colour from …

News
howard_schiller_valeant

Valeant names interim CEO in Pearson’s absence

January 6, 2016
Medical Communications, Sales and Marketing Valeant

Valeant has named company director Howard Schiller as interim chief executive officer to serve while full-time boss Michael Pearson is …

Appointment
Alzheimer's brain

The case for adaptive trials in dementia

January 6, 2016
Manufacturing and Production, Research and Development Alzheimer's, Alzheimer's disease, adaptive trials, research

An ageing population and widespread chronic neuro-degenerative disease will make dementia an ever increasing burden on society, families and the …

Feature
NIHR logo

Roche teams with DH for drug repurposing trial

January 6, 2016
Research and Development DH, NIHR, Off Patent Drugs Bill, Off-Patent Drugs Bill, RoActemra, Roche, drug repurposing, tocilizumab

Roche and the UK Department of Health have launched a trial, to explore whether one of the company’s treatments for …

News
Enterome logo

Takeda and Enterome collaborate on new therapeutics for stomach disorders

January 6, 2016
Research and Development Enterome, Takeda, gastrointestinal, inflammatory bowel syndrome, irritable bowel syndrome

Takeda and Enterome Bioscience have entered a drug discovery collaboration to research and develop potential new therapeutics for disorders including …

News
Merck/MSD

MSD chooses partner to develop ‘game-changing’ cancer therapies

January 6, 2016
Research and Development CPABs, Cancer, Cell-Penetrating Alphabodies, Complix, MSD, autoimmune diseases

MSD has entered a research collaboration with biopharma company Complix, using the company’s proprietary technology to develop new treatments for …

News
afrezza_insulin

Sanofi abandons MannKind’s failed inhalable insulin

January 6, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Afrezza, Mannkind, Sanofi, insulin

Sanofi is to exit a licensing and co-marketing deal with MannKind for the inhalable insulin Afrezza, after disappointing sales figures …

News
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026